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Abstract
Background: Scavenger receptors are important components of the innate immune system in the
lung, allowing alveolar macrophages to bind and phagocytose numerous unopsonized targets. Mice
with genetic deletions of scavenger receptors, such as SR-A and MARCO, are susceptible to
infection or inflammation from inhaled pathogens or dusts. However, the signaling pathways
required for scavenger receptor-mediated phagocytosis of unopsonized particles have not been
characterized.
Methods:  We developed a scanning cytometry-based high-throughput assay of macrophage
phagocytosis that quantitates bound and internalized unopsonized latex beads. This assay allowed
the testing of a panel of signaling inhibitors which have previously been shown to target opsonin-
dependent phagocytosis for their effect on unopsonized bead uptake by human in vitro-derived
alveolar macrophage-like cells. The non-selective scavenger receptor inhibitor poly(I) and the actin
destabilizer cytochalasin D were used to validate the assay and caused near complete abrogation
of bead binding and internalization, respectively.
Results: Microtubule destabilization using nocodazole dramatically inhibited bead internalization.
Internalization was also significantly reduced by inhibitors of tyrosine kinases (genistein and
herbimycin A), protein kinase C (staurosporine, chelerythrine chloride and Gö 6976),
phosphoinositide-3 kinase (LY294002 and wortmannin), and the JNK and ERK pathways. In
contrast, inhibition of phospholipase C by U-73122 had no effect.
Conclusion: These data indicate the utility of scanning cytometry for the analysis of phagocytosis
and that phagocytosis of unopsonized particles has both shared and distinct features when
compared to opsonin-mediated phagocytosis.
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Background
Lung infection is responsible for more disability-adjusted
life years lost than any other disease [1] and high levels of
inhaled dusts have been linked in several epidemiological
studies to increases in ear and airway infections, cardio-
vascular disease, lung cancer and mortality [2-5]. Alveolar
macrophages (AMs) are a first line of defense against
inhaled bacteria and environmental dusts. Therefore,
understanding the mechanism by which AMs defend
against inhaled insults is crucial. Since contact with
inhaled particles often takes place before an antibody
response has occurred or with particles for which specific
antibodies are not readily made, the AM relies on innate
receptors to recognize inhaled particles.
Scavenger receptors (SRs) are a key component of the
innate immune system. In addition to their well-known
role in low-density lipoprotein metabolism, SRs play a
critical role in AM clearance of inhaled particles by bind-
ing and allowing the cells to internalize unopsonized
microorganisms, apoptotic bodies and environmental
dusts [6,7]. General blockade of SRs using polyanionic
inhibitors results in a dramatic reduction of AM uptake of
residual oil fly ash, ambient air particles, diesel dust, iron
oxide, titanium dioxide, silica, Escherichia coli  Staphy-
lococcus aureus  8-11]. Specific blockade and transfection
of members of the SR family have shown these receptors
to be capable of binding several Gram-positive and Gram-
negative bacteria as well as isolated lipopolysaccharide
and lipotechoic acid [12-21]. In addition, mice deficient
in SR-A or MARCO demonstrate reduced bacterial clear-
ance, increased pulmonary inflammation and increased
mortality following an intranasal challenge with Strepto-
coccus Pneumoniae [10,22]. Furthermore, MARCO can
bind CpG DNA [23], whereas blockade of MARCO with a
monoclonal antibody dramatically reduces AM uptake of
titanium dioxide, iron oxide, silica and latex beads
[24,22,25]. SR-A and MARCO, therefore, are clearly criti-
cal components of pulmonary host defense. However, it is
important to point out that AMs also express several other
less well-characterized SRs including LOX-1, SR-PSOX
and SRCL [10]. These SRs are capable of binding bacteria
[26-28] and might also contribute to the AM response to
inhaled insults.
While it is clear that SR-initiated uptake of inhaled parti-
cles is critically important for lung defense, it is currently
not known which signaling pathways are necessary for SR-
mediated phagocytosis. In contrast, phagocytosis of
opsonized particles (via Fc or complement receptors) has
been well characterized [29]. Many characteristics of
opsonin-mediated phagocytosis are shared by both Fc and
complement receptors (such as signaling by tyrosine
kinase, protein kinase C (PKC), phosphoinositide-3
kinase (PI-3K), mitogen activated protein kinases (MAPK)
and phospholipase Cγ (PLCγ)). In contrast, some charac-
teristics are unique to one receptor pathway (such as sen-
sitivity of complement-mediated uptake to microtubule
inhibitors) [30]. Many of these opsonin-mediated phago-
cytic signaling pathways have also been implicated in
non-phagocytic SR-mediated responses such as cytokine
production and lipoprotein endocytosis [31-38]. We
hypothesized that these pathways would also be necessary
for SR-mediated phagocytosis. To test this, we employed a
battery of well-established signaling inhibitors and a
novel high-throughput fluorescence phagocytosis assay.
AMs are known to express a wide array of SRs with over-
lapping ligand specificities. Therefore, it is likely that
inhaled particles are simultaneously bound by multiple
SR family members. Since the underlying biology of the
particle-AM interaction is more complicated than a simple
one ligand/one receptor interaction, we chose a target par-
ticle (latex spheres) that likewise binds multiple SRs to
more closely model the true physiology of particle-AM
interactions. It should be noted that the latex sphere has
long been used as a model for inhaled particulates and is
similar to 'real world' particles in terms of its SR-mediated
uptake by AM [10,39,9,40,41,25,42].
Methods
Cell isolation, differentiation and characterization
Discarded platelet apheresis collars were obtained from
the Kraft Family Blood Donor Center at the Dana-Farber
Cancer Institute (Boston, MA, USA). Buffy coats were har-
vested from these collars and enriched for monocytes
using the RosetteSep Monocyte Enrichment kit (Stem Cell
Technologies, Vancouver, BC, Canada). Monocytes were
then cultured in Vuelife bags (American Fluoroseal,
Gaithersburg, MD, USA) for 11 days at 5% CO2 and 37°C
in RPMI/10% FBS/20 μg/ml gentamicin supplemented
with 20 ng/ml human granulocyte/macrophage-colony
stimulating factor (GM-CSF, Peprotech, Rocky Hill, NJ,
USA). GM-CSF matured MØ (GM-MØ) were then har-
vested and resuspended at 1 × 106/ml in RPMI/10% FBS.
1 × 105 cells were dispensed into black-walled 96 well
Micro-Clear plates (Greiner Bio-One, Monroe, NC, USA).
For some experiments, the number of cells per well was
altered but the volume remained constant. After plating
and adherence, GM-MØ were incubated for 40–44 hours,
and then used to measure particle binding and internali-
zation.
Some GM-MØ were characterized by flow cytometry
before being plated for experiments. Cells were stained
with anti-PSOX (10 μg/ml, provided by Dr. Kimihisa
Ichikawa, Sankyo, Tokyo, Japan), anti-LOX-1 (10 μg/ml,
Cell Sciences, Inc., Canton, MA, USA), anti-SR-A (10 μg/
ml, provided by Dr. Motohiro Takeya, Kumamoto Univer-
sity, Kumamoto, Japan), anti-CD68 (10 μg/ml, Dako,Respiratory Research 2008, 9:59 http://respiratory-research.com/content/9/1/59
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Carpinteria, CA, USA), anti-CD14 (3.3 μg/ml), anti-HLA-
DR (10 μg/ml), anti-HLA-DQ (10 μg/ml) or equal con-
centrations of isotype matched control antibodies (all
from BD Biosciences, Rockville, MD, USA) in PBS with 2
mg/ml bovine serum albumin (BSA) and 4 mg/ml human
IgG (both from Sigma, St. Louis, MO, USA). This step was
followed by staining with 20 μg/ml Alexafluor 488
labeled F(ab')2 goat anti-mouse antibodies (Invitrogen,
Carlsbad, CA, USA) and fixation in PBS with 1% parafor-
maldehyde. Other cells were stained with 10 μg/ml PLK-1
(anti-MARCO [10]) or control IgG that had been bioti-
nylated using biotin-X-NHS (Calbiochem, San Diego, CA,
USA). This was followed by secondary staining with 7.5
μg/ml streptavidin-phycoerythrin (Invitrogen) and fixa-
tion as described above. Cellular fluorescence was meas-
ured using a Coulter Epics Elite flow cytometer (Beckman
Coulter, Miami, FL, USA).
Cells were also evaluated for their ability to bind unop-
sonized latex beads in the presence or absence of SR
inhibitors. One hundred microliters of GM-MØ (sus-
pended at 2 × 106/ml in HBSS/0.3% BSA) were plated in
each well of a low adherence 96-well plate (Corning,
Corning NY, USA). One hundred microliters of 20 μg/ml
polyinosinic acid (poly (I)), 20 μg/ml chondroitin sulfate
(both from Sigma), 20 μg/ml PLK-1 mAb or 20 μg/ml
mIgG3 isotype control (eBioscience, San Diego, CA, USA)
were added and cells were allowed to incubate for 10 min-
utes at 37°C. One hundred microliters of green fluores-
cent latex beads (1 μm, Invitrogen) were added at a
concentration of 1 × 108/ml in HBSS/0.3%BSA with or
without 10 μg/ml poly(I), 10 μg/ml chondroitin sulfate,
10 μg/ml PLK-1 or 10 μg/ml mIgG3. This corresponds to a
50:1 bead to cell ratio. Cells were incubated for 30 min-
utes at 37°C, with gentle pipetting every 10 minutes to
resuspend the cells and beads. After incubation, the assay
was stopped by chilling cells on ice and analyzing fluores-
cence by flow cytometry.
For mouse studies, primary AMs were isolated from
C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME,
USA). Immediately before bronchialveolar lavage, mice
were euthanized by an overdose of Phenobarbital. The
lungs were lavaged six times with 0.8 ml of ice-cold PBS.
Cell purity and yield was determined using a hemocytom-
eter. Murine AMs were cultured in black-walled 96 well
Micro-Clear plates in RPMI/10% FBS for 40–44 hours
before phagocytosis assays were performed as described
for GM-MØ.
Preparation of biotinylated latex beads
Biotin-BSA was generated by incubating 50 mg of tissue
culture grade BSA (Sigma) with 30 mg biotin-X-NHS in 10
ml PBS for one hour at room temperature. Unconjugated
biotin was removed by extensive dialysis. Green fluores-
cent carboxylated latex beads (1 μm, Invitrogen) were cen-
trifuged at high speed and washed twice in 2-(N-
morpholino)ethanesulfonic acid (MES, Calbiochem)
buffer (19.2 mg/ml, pH 6.0). Beads were suspended at 5 ×
109 per ml in MES buffer. Water-soluble carbodimide
(WSC, Calbiochem) was freshly dissolved in MES buffer
and beads were incubated at room temperature for one
hour with 10 mg/ml WSC. Beads were washed twice in 0.5
× PBS and resuspended in water. An equal volume of
biotin-BSA was added for a final concentration of 2 mg/
ml BSA in 0.5 × PBS. Beads were incubated overnight at
room temperature and then centrifuged at high speed.
Beads were then resuspended in 0.5 × PBS with 40 mM
glycine and incubated for one hour. Finally, beads were
washed twice in PBS containing 0.2% BSA and 0.01%
sodium azide and stored at 4°C.
Internalization assay
All reagents and buffers were at room temperature when
added to cells and all incubations were performed in
warm (37°C) humid air unless otherwise noted. All fluo-
rescent dyes were purchased from Invitrogen. Cells were
incubated with CellTracker Blue at 100 μM in HBSS with
Ca++ and Mg++ (Cambrex, East Rutherford, NJ, USA) for 40
minutes followed by a 30 minute recovery period in assay
buffer (HBSS/0.3% BSA). Inhibitors (Table 1) or DMSO
were then added for 20 minutes. Poly(I), cytochalasin D,
nocodazole, staurosporine, wortmannin and herbimycin
A were purchased from Sigma. All other inhibitors were
purchased from Calbiochem. GM-MØ were then incu-
bated for 20 minutes with bead suspension (2 × 108
beads/ml) +/- inhibitors for bead binding and internaliza-
tion. Cells were then washed 2 × 250 μl with assay buffer,
covered with fresh buffer +/- inhibitors and incubated for
an additional 20 minutes to allow for further bead inter-
nalization (the cells were, therefore, incubated with inhib-
itors for a grand total of 60 minutes). After this the cells
were washed and extracellular beads were labeled on ice
for 30 minutes using streptavidin-Texas Red (20 μg/ml in
assay buffer). After a final wash with 250 μl assay buffer,
cells were fixed with 4% paraformaldehyde in PBS. The
fixative was removed after 30 minutes and cell nuclei were
stained for 30 minutes with 3 μg/ml of Hoechst 33342.
The Hoechst dye was then removed and wells were filled
with 100 μl of 4% paraformaldehyde in PBS for storage.
Image Acquisition and Data Analysis
Images of adherent cells were collected using the Pathway
HT bioimager (BD Biosciences). Cells were both illumi-
nated through and fluorescence emission was collected
from the bottom of the plate using a 20 × NA075 lens
(Olympus, Center Valley, PA, USA) and a field size of
approximately 300 μm square. All images were collected
using flat field correction and 2 × 2 binning of pixels. Auto
focus was carried out using the fluorescence emission ofRespiratory Research 2008, 9:59 http://respiratory-research.com/content/9/1/59
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Hoechst and CellTracker Blue, which share the same exci-
tation and emission spectra. Confocal images of bead flu-
orescence (488 BP excitation, 515 LP dichroic, 515 LP
emission filters), Texas Red (560 BP excitation, 595 LP
dichroic, 645 LP emission filters) and Hoechst/Cell-
Tracker Blue (380 BP excitation, 400 LP dichroic, 435 LP
emission filters) were collected every 1.7 μm for a total of
10 sections. The dyes were illuminated sequentially and
the confocal images collected were collapsed, creating
new images with clear definition of all beads within each
cell.
Cell segmentation for each image was achieved using a
combination of the Hoechst signal (to identify single
cells) and the CellTracker Blue signal (to define the cell
borders). Using the collapsed stacks of confocal images,
software was developed to define the cells (blue emission
image), count the number of beads per cell (green emis-
sion image) and determine if the beads are outside the cell
(red emission image) using custom software developed in
MATLAB (The Mathworks, Inc., Natick, MA, USA).
Hoechst/CellTracker Blue images were processed to
reduce noise, enhance contrast and correct for non-uni-
form field brightness. A gradient-facilitated watershed seg-
mentation algorithm was used to identify and label
individual cells. Cell sizes (profile areas) were calculated
as the number of pixels in segmented cell objects (col-
lapsed stack images). Cell volumes were calculated as the
sum of the cell profile areas of the individual confocal
images comprising collapsed stacks. Green fluorescent (all
beads) and red fluorescent (external beads) images were
sharpened and contrast enhanced. Watershed segmenta-
tion was used to identify and label individual bead
objects. Labeled bead objects within the "all beads" image
were classified as "internal" if they had less than 20%
overlap with an external bead object. Bead objects sharing
one or more pixel with any cell object were considered to
be associated with that cell. All partial cell images along
the edges of the field were omitted from analysis.
Bead binding was calculated as the average number of
cell-associated beads per cell. Typically between 1200 and
1800 total cells were counted per donor per condition.
Percent internalization was calculated as the number of
internalized beads divided by the total number of cell-
associated beads for each cell, then multiplied by 100. Sig-
nificant differences were calculated for the poly(I) data
using Students paired t-test. For the cell density data, the
Spearman correlation test was performed. For all other
data, significant differences were calculated using one-way
ANOVA followed by Bonferroni's multiple comparison of
all means. An unpaired ANOVA was used in the analysis
of the protein tyrosine kinase data in Figure 8. For all
other data, a paired ANOVA was used. Prism 4 for the
Macintosh (Graphpad Software, San Diego, CA, USA) was
used for all graphing and statistical calculations.
Results
Characterization of GM-MØ
Monocytes are typically matured into MØ in vitro using M-
CSF. However, AM are unusual in that they require GM-
CSF, but not M-CSF, for their development in vivo [43-47].
Therefore, we followed the GM-CSF-based differentiation
protocol of Akagawa, et al., designed to produce mono-
cyte-derived MØ with a distinctly AM-like phenotype
(GM-MØ) [48]. Both AM and GM-MØ have been shown
to produce lower levels of H2O2, express higher levels of
catalase and are more resistant to H2O2 toxicity when
compared to M-CSF derived MØ. Furthermore, AM and
GM-MØ (but not M-CSF derived MØ) express HLA-DQ
and are resistant to HIV infection, but susceptible to Myco-
bacterium tuberculosis infection [48,49]. Finally, we are
confident that GM-MØ are an appropriate model for pri-
mary AMs in that several of the inhibitors described in this
Table 1: Summary of Inhibitors Tested.
Inhibitor Target Final Concentration Vehicle
Poly(I) SR binding 10 μg/ml PBS
Cytochalasin D filamentous actin 15 μM DMSO
Nocodazole microtubules 25 μM DMSO
Staurosporine protein kinases 1 μM DMSO
Chelerythrine Cl PKC 25 μM DMSO
Gö 6976 PKC 10 μM DMSO
Wortmannin PI-3K 0.04 μM DMSO
LY294002 PI-3K 200 μM DMSO
Genistein tyrosine kinases 100 μM DMSO
Herbimycin A tyrosine kinases 80 μM DMSO
MEK inhibitor I MEK 200 μM DMSO
JNK inhibitor I JNK 4 μMP B S
JNK control inactive analog of JNK inhibitor I 4 μMP B S
U-73122 phospholipase C 10 μM DMSO
U-73343 inactive analog of U-73122 10 μM DMSORespiratory Research 2008, 9:59 http://respiratory-research.com/content/9/1/59
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communication (genistein, herbimycin A, wortmannin,
nocodazole and staurosporine) were also tested for their
ability to inhibit phagocytosis of beads by primary murine
AM. In all cases, the results were comparable to those
obtained using GM-MØ (data not shown).
It should be noted that, unlike murine bone marrow,
incubation of human monocytes with GM-CSF alone
does not produce dendritic cells, as evidenced by the mor-
phology and surface marker expression of GM-MØ. GM-
MØ were harvested after 11 days of culture in GM-CSF-
supplemented media and immunolabeled to measure
surface expression of general macrophage markers as well
as markers which can differentiate between alveolar/GM-
MØ and the more traditional M-CSF matured MØ. As
shown in Figure 1, greater than 90% of GM-MØ stain pos-
itive for the MØ surface proteins CD14 and HLA-DR and
demonstrate a MØ-like morphology when analyzed by
light microscopy, confirming their identity as MØ. These
cells are also positive for both HLA-DQ and MARCO (Fig-
ure 2), a phenotype consistent with both GM-MØ and pri-
mary AMs [10,48-51,25,52]. In addition, GM-MØ were
labeled for SRs known to be present on primary AMs
[53,54,10]. As shown in Figure 2, GM-MØ are weakly pos-
itive for CD68 and strongly positive for MARCO, PSOX
and SR-A.
Our findings also confirm that SRs are involved in the
binding of unopsonized latex beads. As shown in Figures
2F and 2G, bead uptake is dramatically inhibited by either
the broad SR blocker poly(I) or the MARCO-specific SR
blocker mAb PLK-1. These agents reduced the fluorescent
bead signal by 80% and 62% respectively, whereas their
control reagents (chondroitin sulfate and mIgG3) had no
effect. Taken together, these data suggest that GM-MØ
accurately model primary AMs in their expression of a
wide range of SRs and that their interaction with unop-
sonized beads involves MARCO (and likely other SRs as
well).
High throughput direct measurement of phagocytosis
A high throughput phagocytosis assay was developed to
provide rapid and direct measurement of both particle
binding and internalization. For this assay, GM-MØ are
first incubated with CellTracker Blue, which provides a
uniform label of the whole cell to facilitate cytometric
identification. The GM-MØ are then allowed to bind and
ingest biotinylated green fluorescent latex beads, followed
by incubation with streptavidin-Texas Red to label exter-
nal beads. Analysis with a scanning cytometer produces
images in which beads that are bound, but not internal-
ized, are clearly distinguishable from those which are
internalized. Figures 3A–D are typical examples of images
produced by this technique. In Figures 3A and 3B, phago-
cytosis has been inhibited by cytochalasin D treatment. As
a result, all of the beads are extracellular and appear as yel-
low, due to the colocalization of red and green fluores-
cence. In contrast, the cells in Figures 3C and 3D have
been allowed to internalize beads. In these images, some
beads are extracellular (appearing as yellow) while others
have been internalized (appearing as green). The cells in
these images can be automatically identified ('seg-
mented') and the number of beads per cell counted using
a combination of commercial and custom software (Fig-
ure 3B and 3D).
In order to validate this technique, GM-MØ were cultured
with known inhibitors of SR binding and phagocytosis
before being incubated with fluorescent beads. We
observed a nearly complete (96%) reduction in the
number of beads bound by cells in the presence of the SR
blocker poly(I) (Figure 4A). In contrast, the actin destabi-
lizer cytochalasin D has no effect on total bead binding,
but decreases the number of beads internalized by 90%
when compared to the DMSO control (Figures 4B and
4C). To compare the results of software image analysis to
human quantitation of the same images, beads per cell
were manually counted for 50 cells in both the control
and cytochalasin D treated conditions. These results were
quite similar to those obtained by software analysis and
are shown in Table 2. Hence, our software quantification
technique is capable of accurately counting and distin-
guishing between beads that have been internalized and
beads that have been bound, but not internalized.
Binding and internalization are differentially affected by 
cell density
To determine the optimal cell concentration for this assay,
we compared results using a range of cell densities. The
data collected indicate that cell density affects cell size,
and has considerable and opposing effects on bead bind-
ing and internalization (Figure 5). Higher plating densi-
ties are associated with reduced cell size, as measured by
pixels per cell profile in collapsed stack images, (r = -
0.972, p < 0.001). Comparison of cell sizes and cell vol-
umes calculated from confocal slices confirmed that cell
size accurately reflects cell volume (n = 95 cells, r = 0.971,
p < 0.0001, data not shown). As cell density increases, the
number of beads bound per cell decreases significantly (r
= -0.853, p < 0.001). This could be due to reduced cell size
and/or increased cell-to-cell contact, thereby reducing the
cellular surface area available for bead binding. In con-
trast, increasing the cell density dramatically augments the
percentage of bound beads that are internalized (e.g.,
increasing the density of the cells from 54 to 180 cells per
field resulted in a 60% increase in the percentage of inter-
nalized beads (r = 0.622, p < 0.05)), an observation that
cannot easily be explained by a reduction in cell size.
Taken together, these data indicate that the density used
for in vitro analysis of GM-MØ has a significant influenceRespiratory Research 2008, 9:59 http://respiratory-research.com/content/9/1/59
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Characterization of GM-MØ Figure 1
Characterization of GM-MØ. CD14 (A), HLA-DR (B) and HLA-DQ (C) expression were evaluated by flow cytometry. 
Solid lines represent the fluorescence of stained cells, while dashed lines represent the results from control antibodies. Data 
are representative of experiments performed on cells from three donors. Cytocentrifuge preparations illustrating monocyte 
and macrophage morphology before (D) and after (E) maturation with GM-CSF were captured at equal magnification (200×).
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Characterization of SRs expressed by GM-MØ Figure 2
Characterization of SRs expressed by GM-MØ. MARCO (A), PSOX (B), LOX-1 (C), SR-A (D) and CD68 (E) expression 
as well as fluorescent bead binding in the presence of poly(I) (F) or an anti-MARCO mAb (G) were evaluated by flow cytome-
try. Data are representative of experiments performed on cells from three (A-E) or five (F and G) donors.
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on phagocytic parameters. For all subsequent experi-
ments, cells were plated at 1 × 105 cells per well.
Microtubule destabilization inhibits SR mediated 
internalization
Although filamentous actin is required for phagocytosis in
general, the requirement for microtubules depends upon
which phagocytic receptor is involved. For example,
inhibiting microtubule function blocks complement
receptor-mediated, but not Fc receptor-mediated, particle
internalization [30,55]. In order to determine if SR-medi-
ated phagocytosis requires microtubules, GM-MØ were
analyzed for their ability to bind and internalize latex
beads in the presence of the microtubule destabilizer noc-
odazole. Nocodazole treatment has no effect on the total
number of beads bound per cell (data not shown), sug-
gesting that SRs do not require microtubules for particle
binding. In contrast, nocodazole treatment reduces the
proportion of internalized beads by 50% when compared
to the DMSO control (Figure 6). We conclude that SR-
mediated internalization is similar to complement recep-
tor-mediated phagocytosis in that they both require func-
tional microtubules.
Effect of signaling pathway inhibitors on SR-mediated 
phagocytosis
A large number of signaling molecules have been impli-
cated in MØ phagocytosis [56,57]. However, most of this
work has been performed using IgG or (to a lesser extent)
complement opsonized particles. Very little is known
about which signaling pathways are required for SR-medi-
ated phagocytosis. Our strategy was to analyze these path-
ways using a panel of relevant pharmacologic inhibitors,
an approach facilitated by the high throughput assay
described above.
Tyrosine kinases and PKC are both known to be involved
in Fc-receptor mediated phagocytosis [57]. Therefore, we
tested the effect of protein tyrosine kinase and PKC inhib-
Binding and phagocytosis assay Figure 3
Binding and phagocytosis assay. Adherent GM-MØ were 
treated with cytochalasin D (A and B) to block internalization 
or vehicle control (DMSO, C and D) before incubation with 
biotinylated green fluorescent latex beads and labeling of 
extracellular beads with streptavidin-Texas Red. Images 
obtained by scanning cytometry show intracellular beads in 
green, while extracellular beads are in yellow (due to the 
colocalization of red and green fluorescence). Panels A and C 
depict the fluorescence images obtained by the scanning 
cytometer, while panels B and D depict the same images 
after automated segmenting and bead identification. Scale 
bars represent 20 μm.
A.)
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Table 2: Manual vs. Computer Enumeration of Cell-Associated 
Beads.
Internalized Beads Extracellular Beads
Control Cytochalasin D Control Cytochalasin D
Manual 126 10 57 221
Computer 130 11 69 234
Quantification of bead binding and internalization Figure 4
Quantification of bead binding and internalization. 
Adherent GM-MØ were pretreated with either poly(I) (A) 
or cytochalasin D (B and C) before incubation with fluores-
cent latex beads. Cells were analyzed for total bead binding 
(A and B) and percent internalization (C). Bars represent the 
means of four (A) or three (B and C) donors +/- the standard 
deviation. For each donor, three fields from each of three 
replicate wells were analyzed. *p < 0.01 **p < 0.001 when 
compared to either the control or DMSO conditions.
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itors on SR-mediated phagocytosis (Figures 7 and 8). Inhi-
bition of PKC with staurosporine results in a significant
reduction in the number of beads internalized. However,
staurosporine is known to inhibit a number of other pro-
tein kinases in addition to PKC. In order to definitively
show that PKC is required, the PKC specific inhibitors
chelerythrine chloride and Gö 6976 were used. These
inhibitors cause dramatic (77% and 86%, respectively)
reductions in bead internalization. Similarly, treatment
with the protein tyrosine kinase inhibitors genistein and
herbimycin A result in a 51% and 64% reduction in inter-
nalization, respectively. These data show that PKC and
tyrosine kinase activities are important for non-opsonic
phagocytosis.
The MAPK family of protein kinases is critical for Fc recep-
tor mediated phagocytosis as well as cell cycle progression
and a number of other cytoskeletal processes. Since PKC
and tyrosine kinases are known to stimulate MAPK [58],
inhibitors of the JNK and ERK MAPK pathways were
tested for their ability to inhibit SR-mediated phagocyto-
sis. Inhibition of either of these MAPK pathways blocks
internalization. The JNK inhibitor reduces bead internali-
zation by 28% while the inactive analog used as a control
does not cause a statistically significant reduction (Figure
9A). Inhibition of the ERK pathway was achieved using an
inhibitor of the upstream kinase, MEK. Treatment with
this inhibitor reduces phagocytosis by 42% when com-
pared to DMSO control (Figure 9B).
In addition to the protein kinases mentioned above, the
lipid modifying enzymes PI-3K and PLCγ have also been
shown to play a role in MØ phagocytosis [57]. Therefore,
the PI-3K inhibitors wortmannin and LY294002 and the
PLCγ inhibitor U-73122 were used to block these enzymes
before challenging GM-MØ with latex beads As shown in
Figure 10A, wortmannin inhibits bead internalization by
59%, while LY294002 causes an even greater inhibition
(78%) (Figure 10B). These data demonstrate that PI-3K is
required for optimal SR-mediated phagocytosis. However,
unlike PI-3K, PLCγ does not appear to be necessary, as U-
73122 is unable to block internalization at the concentra-
tion tested (Figure 11).
Interestingly, while most of the inhibitors shown in Fig-
ures 7, 8, 9, 10, 11 block internalization, none of them
have a significant effect on particle binding, cell size or the
number of cells per field (data not shown). This indicates
that SRs do not require PKC, tyrosine kinase, MAPK, PI-3K
or PLCγ signaling to effectively bind unopsonized parti-
cles. In addition, the fact that cell size and number are
unaffected by the inhibitors used demonstrates that these
inhibitors did not affect cell viability. This is confirmed by
Bead binding and internalization are cell density dependent Figure 5
Bead binding and internalization are cell density 
dependent. GM-MØ were plated at 5 × 104 to 1.25 × 105 
cells/well and cultured overnight before incubation with fluo-
rescent latex beads. At the end of the experiment, cell den-
sity for each well was calculated as the average number of 
cells per field from three fields. Cells were analyzed for total 
bead binding (A), cell size (B) and bead internalization (C). 
Points represent the means of three wells each. Lines repre-
sent the best-fit linear regression. Data are pooled from 
three donors.
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Microtubule destabilization inhibits SR mediated phagocytosis Figure 6
Microtubule destabilization inhibits SR mediated 
phagocytosis. Adherent GM-MØ were pretreated with 
nocodazole before incubation with fluorescent latex beads. 
Cells were analyzed for the percent internalization of bound 
beads. Bars represent the means of five donors +/- the stand-
ard deviation. For each donor, three fields from each of 
three replicate wells were analyzed. **p < 0.001 when com-
pared to either the control or DMSO conditions.
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the observation that the inhibitors used do not alter cellu-
lar morphology or increase staining with propidium
iodide (data not shown).
Discussion
While the ligand binding characteristics of SRs have been
characterized [6], very little is known about the signaling
pathways utilized during SR-mediated phagocytosis. In
order to address this, we developed a high-throughput
phagocytosis assay capable of distinguishing between
internalized and non-internalized cell-associated parti-
cles. Using this assay, we tested a battery of signaling
inhibitors that are known to block opsonin-mediated
phagocytosis for their effect on opsonin-independent
phagocytosis. We found that microtubules, PKC, tyrosine
kinases, MAPKs and PI-3K are required for optimal SR-
mediated phagocytosis. Furthermore, cell density has a
significant impact on both particle binding and internali-
zation.
As primary human AM are difficult to obtain in large
quantities, we took advantage of a previously published in
vitro human monocyte differentiation scheme that pro-
duces MØ that are phenotypically and physiologically
similar to human AM. In order to confirm our findings,
we tested a subset of inhibitors (genistein, herbimycin A,
wortmannin, nocodazole and staurosporine) for their
effect on bead phagocytosis by primary murine AMs.
Every inhibitor tested significantly decreased bead inter-
nalization. This demonstrates that, at the very least, pro-
tein tyrosine kinases, PKC, PI-3K and microtubules are
necessary for bead phagocytosis by primary murine AM.
These findings are identical to those obtained using GM-
MØ and further establish these cells as a useful model of
primary AM.
Most currently available phagocytosis assays rely on sub-
tracting the number of particles associated with cells in
which internalization has been blocked from the number
of particles associated with cells in which internalization
has not been blocked. The agents used to block phagocy-
tosis are typically cytoskeletal or mitochondrial poisons
such as cytochalasin D or sodium azide (although incuba-
tion at low temperature has also been used) [59-61]. Built
into these indirect techniques is the assumption that the
agent used to block internalization is effective in the par-
ticular cells being studied, yet does not alter the number
of bound extracellular beads.
In some cases (particularly for receptors of unopsonized
targets), this assumption is erroneous, resulting in either
an under- or overestimation of particle internalization.
Protein kinase C blockers inhibit SR mediated phagocytosis Figure 7
Protein kinase C blockers inhibit SR mediated phago-
cytosis. Adherent GM-MØ were pretreated with either 
staurosporine (A), chelerythryine chloride or Gö 6976 (B) 
before incubation with fluorescent latex beads. Cells were 
analyzed for the percent internalization of bound beads. Bars 
represent the means of five (A) or three (B) donors +/- the 
standard deviation. For each donor, three fields from each of 
three replicate wells were analyzed. *p < 0.01 and **p < 
0.001 when compared to either the control or DMSO condi-
tions.
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Protein tyrosine kinase blockers inhibit SR mediated phago- cytosis Figure 8
Protein tyrosine kinase blockers inhibit SR mediated 
phagocytosis. Adherent GM-MØ were pretreated with 
either genistein or herbimycin A before incubation with fluo-
rescent latex beads. Cells were analyzed for the percent 
internalization of bound beads. Bars represent the means of 
at least four donors +/- the standard deviation. For each 
donor, three fields from each of three replicate wells were 
analyzed. **p < 0.001 when compared to either the control 
or DMSO conditions.
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For example, our two-color direct approach definitively
demonstrates that cytochalasin D is an extremely effective
blocker of phagocytosis in GM-MØ (Figure 3D). How-
ever, it does not alter the total number of cell-associated
beads (Figure 3C). Since the total number of cell-associ-
ated beads is the sum of the internalized beads and the
beads that have been bound but not internalized, these
data indicate that cytochalasin D treatment does indeed
alter the number of bound extracellular beads under our
experimental conditions. In this case, using the indirect
single-color technique would have led to a dramatic
underestimation of bead internalization by the untreated
cells. The opposite problem would have been encoun-
tered if a low temperature incubation had been used to
block internalization. This is because, unlike opsonized
particles, the binding of unopsonized beads is tempera-
ture dependent ([42] and our unpublished results).
Given the limitations of the indirect assays mentioned
above, we chose to utilize a direct phagocytosis assay
based on previously developed two-color fluorescence
assays [62,42]. These assays use one intrinsic fluorescent
dye to identify all particles and a second non-cell permea-
ble stain applied after internalization to identify particles
that have not been internalized. These techniques allow
the investigator to distinguish between internalized and
extracellular particles without relying on interventions
that alter the biology of the cell. While these assays over-
come the pitfalls of the indirect assays, they introduce new
difficulties for data collection. For example, analysis by
MAPK blockers inhibit SR mediated phagocytosis Figure 9
MAPK blockers inhibit SR mediated phagocytosis. 
Adherent GM-MØ were pretreated with inhibitors of either 
JNK (A) or MEK (B) before incubation with fluorescent latex 
beads. Cells were analyzed for the percent internalization of 
bound beads. Bars represent the means of five (A) or six (B) 
donors +/- the standard deviation. For each donor, three 
fields from each of three replicate wells were analyzed. **p < 
0.001 when compared to either the control, JNK control or 
DMSO conditions.
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Effect of PI-3K inhibitors on SR mediated phagocytosis Figure 10
Effect of PI-3K inhibitors on SR mediated phagocyto-
sis. Adherent GM-MØ were pretreated with wortmannin 
(A) or LY294002 (B) before being fed fluorescent latex 
beads. Cells were analyzed for the percent internalization of 
bound beads. Bars represent the means of five (A) or three 
(B) donors +/- the standard deviation. For each donor, three 
fields from each of three replicate wells were analyzed. **p < 
0.001 when compared to either the control or DMSO condi-
tions. *p < 0.05 when compared to the control condition.
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flow cytometry can provide exact bead per cell counts for
up to three (or perhaps four) cell-associated beads per cell.
This is due to the high intensity and low bead-to-bead var-
iability of the intrinsic fluorescent dye. However, at higher
bead loads, the absolute number of beads per cell cannot
be determined, as the fluorescent peaks begin to overlap
[63]. Furthermore, the higher variability and lower inten-
sity of staining with the extracellular dye precludes precise
bead per cell counts at even very low bead loads (our
unpublished data). As a result of these issues, results are
typically reported as a ratio of fluorescence intensities
(not absolute bead number) when flow cytometry is used
as a read out. The alternative to flow cytometry (counting
beads by eye using a fluorescent microscope) is tedious
and incompatible with high throughput.
In order to overcome these limitations, we developed a
system using scanning cytometer technology that can
automatically count the number of beads associated with
any given cell and distinguish between internalized and
extracellular beads. This system allows the investigator to
express his or her data as the number of beads per cell and
not simply as fluorescence intensity, even for cells with
high bead loads. While this assay is similar in many
respects to one recently developed by Steinberg and col-
leagues for analysis of opsonized phagocytosis [64], it dif-
fers in that our method involves collecting a set of
confocal images spanning the entire thickness of the cell
that are then collapsed into a single image for analysis.
This technique allows all of the cell-associated beads to be
in focus for the final analysis. In contrast, we have found
that using conventional fluorescence microscopy does not
allow all of the cell-associated beads to remain in focus
simultaneously and therefore excludes some beads from
analysis (data not shown).
The confocal-based phagocytosis assay described in this
report was used to test the hypothesis that SR-mediated
phagocytosis is similar to complement-mediated phago-
cytosis in respect to its sensitivity to a microtubule inhib-
itor. Phagocytosis of opsonized particles by Fc or
complement receptors share a number of characteristics,
including dependence on actin filaments and the accumu-
lation of signaling and actin binding proteins at the site of
the forming phagosome [56]. However, fundamental dif-
ferences exist between these two modes of phagocytosis
[65,66,55,67,68]. These differences have led some to char-
acterize them as type I (Fc receptor-mediated) and type II
(complement receptor-mediated). Microtubule poisons
such as nocodazole paralyze complement-mediated, but
not Fc receptor-mediated, particle internalization [55,30].
In this report we present the first evidence that SR-medi-
ated phagocytosis exhibits a characteristic of type II
phagocytosis in that nocodazole significantly inhibits
internalization.
This report is also the first to show that tyrosine kinases,
PKC, PI-3K and MAPKs are necessary for SR-mediated
phagocytosis by MØ. The requirement for PI-3K and tyro-
sine kinases is consistent with a recent report showing that
PI-3K and the Src kinase Lyn are both required for SR-A-
mediated MØ spreading [69]. Furthermore, treatment of
MØ cell lines with soluble SR ligands results in the tyro-
sine phosphorylation of Src kinases, PLCγ and PI-3K as
well as a tyrosine kinase dependant activation of PKC
[34,33,31,32], suggesting that tyrosine kinase activation
may occur relatively early in the SR signaling cascade.
Consistent with the inhibition of phagocytosis reported
here, inhibition of tyrosine kinases blocks the induction
of urokinase-type plasminogen activator (uPA) and IL-1
expression by THP-1 cells in response to SR ligands
[31,32]. Similarly, pharmacological blockade of PKC
inhibits SR-mediated increases in uPA expression, myelin
endocytosis, prostaglandin E2 release and ERK activation
[32,36,35].
It is surprising to note that the PLCγ inhibitor U-73122
does not affect bead internalization, as U-71322 has pre-
viously been shown to inhibit myelin endocytosis by CR3-
/- microglia [35] and PKC activation in response to oxi-
dized LDL (oxLDL) [33]. However, the experimental con-
ditions in these reports differ greatly from those described
here as the authors use either primary murine microglia or
LPS primed P388D1 cells. The signaling pathways and
receptors utilized by these murine cells could be quite dif-
ferent from those utilized by our primary unprimed
Effect of a PLCγ inhibitor on SR mediated phagocytosis Figure 11
Effect of a PLCγ inhibitor on SR mediated phagocyto-
sis. Adherent GM-MØ were pretreated with U-73122 or the 
inactive analog U-73343 before being fed fluorescent latex 
beads. Cells were analyzed for the percent internalization of 
bound beads. Bars represent the means of four donors +/- 
the standard deviation. For each donor, three fields from 
each of three replicate wells were analyzed.Respiratory Research 2008, 9:59 http://respiratory-research.com/content/9/1/59
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human GM-MØ. Furthermore, while PLCγ is an impor-
tant activator of conventional PKC, atypical PLCγ-inde-
pendent PKC isoenzymes have been shown to be
important in a number of immune cell functions [70].
Our finding that PKC blockers inhibit internalization, but
a PLCγ blocker does not, raises the possibility that GM-
MØ utilize atypical PKC isoenzymes as second messenger
signals for SR-mediated phagocytosis. While this has yet
to be formally demonstrated, it is supported by our find-
ing that an inhibitor of the atypical PKC isoenzyme acti-
vator PI-3K [70] blocks internalization.
Finally, the MAPK family of proteins are known to play an
important role in MØ phagocytosis and have been impli-
cated as downstream signaling molecules for SRs. Stimu-
lation of SRs with fucoidan, oxLDL or poly(I) results in
the activation of JNK and ERK MAPK pathways
[37,31,38]. Furthermore, Lamprou and colleagues
reported that inhibition of these pathways results in a
reduction of latex bead internalization by medfly hemo-
cytes [71,72]. The results of our experiments are consistent
with these reports in that the inhibition of JNK and ERK
pathways results in a reduction of bead internalization.
This suggests that some of the pathways utilized during
SR-mediated phagocytosis are conserved across a broad
spectrum of species.
It is important to note that none of the signaling inhibi-
tors tested in this report had any measurable effect on cell
viability, size, density or bead binding. It is known that
SR-A-mediated acetylated low density lipoprotein binding
and cell adhesion require G proteins [73,74]. This, com-
bined with the previous observation that particle binding
by SRs is highly temperature dependent, suggests that it
contains an active component. However, our data sug-
gests that this active binding mechanism does not require
actin filaments, microtubules, PKC, PI-3K, tyrosine
kinases, MAPKs or PLCγ even though many of these path-
ways are necessary for internalization. Our finding that
cytochalasin D has no effect on bead binding stands in
contrast to the report of Post, et al. in which cytochalasin
D was shown to inhibit SR-A-mediated cell attachment by
35% [73]. This discrepancy may reflect the differences
between the cytoskeletal requirements for particle binding
vs. firm anchorage to a substrate.
Conclusion
We have developed a novel high-throughput assay for par-
ticle phagocytosis that we used to test the signaling path-
ways and cytoskeletal components required for
unopsonized phagocytosis by human monocyte-derived
MØ. We found that filamentous actin, microtubules, PKC,
tyrosine kinases, PI-3K, MEK and JNK are required for
optimal particle internalization while an inhibitor of
PLCγ has no effect.
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